PM

PARI MODY

ARNOLD & PORTER KAYE SCHOLER LLP · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
5
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

Issues related to access, coverage, and payment for cancer drugs. Issues regarding the 340B program, including the Bipartisan 340B Senate Working Group's discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act). Issues related to biopharmaceutical intellectual property and patent matters.
Health Issues · 2024 Q4
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029, 118th Congress).
Medicare/Medicaid · 2024 Q4
Issues related to biopharmaceutical intellectual property and patent matters.
Copyright/Patent/Trademark · 2024 Q4
Issues related to research and development (R&D) tax credits.
Taxation/Internal Revenue Code · 2024 Q4
Issues related to R&D tax credits, including the Tax Relief for American Families and Workers Act of 2024 (H.R. 7024).
Taxation/Internal Revenue Code · 2024 Q3
Issues related to access, coverage, and payment for cancer drugs. Issues regarding the Inflation Reduction Act (Pub. L. No. 117-169), including implementation. Issues related to the Small Biotech Innovation Act (S. 5029).
Medicare/Medicaid · 2024 Q3

Clients

2024 · 5 filings
$██,███ / qtrUnlock

Filing history

2024 Q4
EXELIXIS, INC.
Q4lda.gov →
2024 Q3
EXELIXIS, INC.
Q3lda.gov →
2024 Q2
EXELIXIS, INC.
Q2lda.gov →
2024 Q1
EXELIXIS, INC.
Q1lda.gov →
2024 Q1
EXELIXIS, INC.
RAlda.gov →
Showing recent filings · full history on lda.gov